Mechanism of west nile virus neuroinvasion: A critical appraisal

Viruses

Volumn 6, Issue 7, 2014, Pages 2796-2825

  Suen, Willy W ^a   Prow, Natalie A ^a   Hall, Roy A ^a   Bielefeldt Ohmann, Helle ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Blood brain barrier; Blood CSF barrier; Blood spinal cord barrier; CSF brain barrier; Neuroinvasion; Pathogenesis; Retrograde axonal transport; West Nile virus

Indexed keywords

ANTIVIRUS AGENT; ENHANCED GREEN FLUORESCENT PROTEIN; LUTEOLIN; VIRUS RNA; CELL ADHESION MOLECULE; CELL AGGREGATION FACTORS; VIRUS PROTEIN;

BIOLOGICAL ACTIVITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIEVIRUS A16; ENTEROVIRUS 71; GENETIC ANALYSIS; HAND FOOT AND MOUTH DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION CONTROL; NONHUMAN; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION; RNA REPLICATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; BRAIN; CELL JUNCTION; GENE EXPRESSION REGULATION; GENETICS; HORSE; METABOLISM; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; TIGHT JUNCTION; VIREMIA; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS ENTRY; WEST NILE FLAVIVIRUS;

ADHERENS JUNCTIONS; ANIMALS; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BRAIN; CELL ADHESION MOLECULES; ENCEPHALITIS, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HORSES; HUMANS; SPINAL CORD; TIGHT JUNCTIONS; VIRAL PROTEINS; VIREMIA; VIRUS INTERNALIZATION; WEST NILE VIRUS;

EID: 84904547926     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6072796     Document Type: Review

References (143)

1. Clark, D.C.; Brault, A.C.; Hunsperger, E. The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system. Arch. Virol. 2012, 157, 1423-1440.
2. Steiner, I.; Kennedy, P.G. West nile virus introduction into the new world. Neurology 2013, 81, 1441-1442.
3. Centers for Disease Control and Prevention. West nile virus and other arboviral diseases-United States, 2012. In MMWR; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2013; Volume 62, pp. 513-528.
4. Debiasi, R.L. West nile virus neuroinvasive disease. Curr. Infect. Dis. Rep. 2011, 13, 350-359.
5. Hayes, E.B.; Gubler, D.J. West nile virus: Epidemiology and clinical features of an emerging epidemic in the united states. Annu. Rev. Med. 2006, 57, 181-194.
6. Laperriere, V.; Brugger, K.; Rubel, F. Simulation of the seasonal cycles of bird, equine and human west nile virus cases. Prev. Vet. Med. 2011, 98, 99-110.
7. Tyler, K.L. Emerging viral infections of the central nervous system: Part 1. Arch. Neurol. 2009, 66, 939-948.
8. Castillo-Olivares, J.; Wood, J. West nile virus infection of horses. Vet. Res. 2004, 35, 467-483.
9. Brinton, M.A. The molecular biology of west nile virus: A new invader of the western hemisphere. Annu. Rev. Microbiol. 2002, 56, 371-402.
10. Martin-Acebes, M.A.; Saiz, J.C. West nile virus: A re-emerging pathogen revisited. World J. Virol. 2012, 1, 51-70.
11. Crowder, D.W.; Dykstra, E.A.; Brauner, J.M.; Duffy, A.; Reed, C.; Martin, E.; Peterson, W.; Carriere, Y.; Dutilleul, P.; Owen, J.P. West nile virus prevalence across landscapes is mediated by local effects of agriculture on vector and host communities. PLoS One 2013, 8, e55006.
12. Sampson, B.A.; Ambrosi, C.; Charlot, A.; Reiber, K.; Veress, J.F.; Armbrustmacher, V. The pathology of human west nile virus infection. Hum. Pathol. 2000, 31, 527-531.
13. Angenvoort, J.; Brault, A.C.; Bowen, R.A.; Groschup, M.H. West nile viral infection of equids. Vet. Microbiol. 2013.
14. Bowen, R.A.; Nemeth, N.M. Experimental infections with west nile virus. Curr. Opin. Infect. Dis. 2007, 20, 293-297.
15. Brown, A.N.; Kent, K.A.; Bennett, C.J.; Bernard, K.A. Tissue tropism and neuroinvasion of west nile virus do not differ for two mouse strains with different survival rates. Virology 2007, 368, 422-430.
16. Garcia-Tapia, D.; Hassett, D.E.; Mitchell, W.J., Jr.; Johnson, G.C.; Kleiboeker, S.B. West nile virus encephalitis: Sequential histopathological and immunological events in a murine model of infection. J. Neurovirol. 2007, 13, 130-138.
17. Lim, P.Y.; Louie, K.L.; Styer, L.M.; Shi, P.Y.; Bernard, K.A. Viral pathogenesis in mice is similar for west nile virus derived from mosquito and mammalian cells. Virology 2010, 400, 93-103.
18. Weiner, L.P.; Cole, G.A.; Nathanson, N. Experimental encephalitis following peripheral inoculation of west nile virus in mice of different ages. J. Hyg. (Lond.) 1970, 68, 435-446.
19. Diamond, M.S.; Shrestha, B.; Marri, A.; Mahan, D.; Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by west nile encephalitis virus. J. Virol. 2003, 77, 2578-2586.
20. Ben-Nathan, D.; Lustig, S.; Feuerstein, G. The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of west nile virus. Arch. Virol. 1989, 109, 1-10.
21. Ben-Nathan, D.; Lustig, S.; Kobiler, D. Cold stress-induced neuroinvasiveness of attenuated arboviruses is not solely mediated by corticosterone. Arch. Virol. 1996, 141, 1221-1229.
22. Diamond, M.S.; Sitati, E.M.; Friend, L.D.; Higgs, S.; Shrestha, B.; Engle, M. A critical role for induced igm in the protection against west nile virus infection. J. Exp. Med. 2003, 198, 1853-1862.
23. Wang, T.; Scully, E.; Yin, Z.; Kim, J.H.; Wang, S.; Yan, J.; Mamula, M.; Anderson, J.F.; Craft, J.; Fikrig, E. Ifn-gamma-producing gamma delta t cells help control murine west nile virus infection. J. Immunol. 2003, 171, 2524-2531.
24. Shrestha, B.; Diamond, M.S. Role of cd8(+) t cells in control of west nile virus infection. J. Virol. 2004, 78, 8312-8321.
25. Samuel, M.A.; Diamond, M.S. Alpha/beta interferon protects against lethal west nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79, 13350-13361.
26. Mehlhop, E.; Diamond, M.S. Protective immune responses against west nile virus are primed by distinct complement activation pathways. J. Exp. Med. 2006, 203, 1371-1381.
27. Samuel, M.A.; Whitby, K.; Keller, B.C.; Marri, A.; Barchet, W.; Williams, B.R.; Silverman, R.H.; Gale, M. Jr.; Diamond, M.S. Pkr and rnase l contribute to protection against lethal west nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 2006, 80, 7009-7019.
28. Shrestha, B.; Wang, T.; Samuel, M.A.; Whitby, K.; Craft, J.; Fikrig, E.; Diamond, M.S. Gamma interferon plays a crucial early antiviral role in protection against west nile virus infection. J. Virol. 2006, 80, 5338-5348.
29. Wang, T.; Gao, Y.; Scully, E.; Davis, C.T.; Anderson, J.F.; Welte, T.; Ledizet, M.; Koski, R.; Madri, J.A.; Barrett, A.; et al. Gamma delta t cells facilitate adaptive immunity against west nile virus infection in mice. J. Immunol. 2006, 177, 1825-1832.
30. Correale, J.; Villa, A. Cellular elements of the blood-brain barrier. Neurochem. Res. 2009, 34, 2067-2077.
31. Abbott, N.J.; Patabendige, A.A.K.; Dolman, D.E.M.; Yusof, S.R.; Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37, 13-25.
32. Verma, S.; Lo, Y.; Chapagain, M.; Lum, S.; Kumar, M.; Gurjav, U.; Luo, H.; Nakatsuka, A.; Nerurkar, V.R. West nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology 2009, 385, 425-433.
33. Hasebe, R.; Suzuki, T.; Makino, Y.; Igarashi, M.; Yamanouchi, S.; Maeda, A.; Horiuchi, M.; Sawa, H.; Kimura, T. Transcellular transport of west nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein. BMC Microbiol. 2010, 10, 165-165.
34. Liou, M.L.; Hsu, C.Y. Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain. Cell Tissue Res. 1998, 293, 389-394.
35. Dropulic, B.; Masters, C.L. Entry of neurotropic arboviruses into the central nervous system: An in vitro study using mouse brain endothelium. J. Infect. Dis. 1990, 161, 685-691.
36. German, A.C.; Myint, K.S.; Mai, N.T.; Pomeroy, I.; Phu, N.H.; Tzartos, J.; Winter, P.; Collett, J.; Farrar, J.; Barrett, A.; et al. A preliminary neuropathological study of japanese encephalitis in humans and a mouse model. Trans. R. Soc. Trop. Med. Hyg. 2006, 100, 1135-1145.
37. Cantile, C.; Del Piero, F.; di Guardo, G.; Arispici, M. Pathologic and immunohistochemical findings in naturally occuring west nile virus infection in horses. Vet. Pathol. 2001, 38, 414-421.
38. Kong, K.F.; Delroux, K.; Wang, X.; Qian, F.; Arjona, A.; Malawista, S.E.; Fikrig, E.; Montgomery, R.R. Dysregulation of tlr3 impairs the innate immune response to west nile virus in the elderly. J. Virol. 2008, 82, 7613-7623.
39. Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J.F.; Fikrig, E.; Flavell, R.A. Toll-like receptor 3 mediates west nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10, 1366-1373.
40. Arjona, A.; Foellmer, H.G.; Town, T.; Leng, L.; McDonald, C.; Wang, T.; Wong, S.J.; Montgomery, R.R.; Fikrig, E.; Bucala, R. Abrogation of macrophage migration inhibitory factor decreases west nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 2007, 117, 3059-3066.
41. Verma, S.; Kumar, M.; Gurjav, U.; Lum, S.; Nerurkar, V.R. Reversal of west nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 2010, 397, 130-138.
42. Roe, K.; Kumar, M.; Lum, S.; Orillo, B.; Nerurkar, V.R.; Verma, S. West nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J. Gen. Virol. 2012, 93, 1193-1203.
43. Medigeshi, G.R.; Hirsch, A.J.; Brien, J.D.; Uhrlaub, J.L.; Mason, P.W.; Wiley, C.; Nikolich-Zugich, J.; Nelson, J.A. West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J. Virol. 2009, 83, 6125-6134.
44. Xu, Z.; Waeckerlin, R.; Urbanowski, M.D.; van Marle, G.; Hobman, T.C. West nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins. PLoS One 2012, 7, e37886.
45. Shen, J.; Tto, S.S.; Schrieber, L.; King, N.J.C. Early e-selectin, vcam-1, icam-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 1997, 71, 9323-9332.
46. Dai, J.; Wang, P.; Bai, F.; Town, T.; Fikrig, E. Icam-1 participates in the entry of west nile virus into the central nervous system. J. Virol. 2008, 82, 4164-4168.
47. Sigmundsdottir, H.; Butcher, E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 2008, 9, 981-987.
48. Kumar, M.; Roe, K.; Nerurkar, P.V.; Orillo, B.; Thompson, K.S.; Verma, S.; Nerurkar, V.R. Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of type 2 diabetic mouse model infected with west nile virus. J. Neuroinflammation 2014, 11, 80.
49. Getts, D.R.; Terry, R.L.; Getts, M.T.; Muller, M.; Rana, S.; Deffrasnes, C.; Ashhurst, T.M.; Radford, J.; Hofer, M.; Thomas, S.; et al. Targeted blockade in lethal west nile virus encephalitis indicates a crucial role for very late antigen (vla)-4-dependent recruitment of nitric oxide-producing macrophages. J. Neuroinflammation 2012, 9, 1742-2094.
50. Samuel, M.A.; Diamond, M.S. Pathogenesis of west nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 2006, 80, 9349-9360.
51. Sips, G.J.; Wilschut, J.; Smit, J.M. Neuroinvasive flavivirus infections. Rev. Med. Virol. 2012, 22, 69-87.
52. Kramer-Hammerle, S.; Rothenaigner, I.; Wolff, H.; Bell, J.E.; Brack-Werner, R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 2005, 111, 194-213.
53. Kumar, M.; Verma, S.; Nerurkar, V.R. Pro-inflammatory cytokines derived from west nile virus (wnv)-infected sk-n-sh cells mediate neuroinflammatory markers and neuronal death. J. Neuroinflammation 2010, 7, 73-73.
54. Suthar, M.S.; Diamond, M.S.; Gale, M., Jr. West nile virus infection and immunity. Nat. Rev. Microbiol. 2013, 11, 115-128.
55. Lim, S.M.; Koraka, P.; Osterhaus, A.D.; Martina, B.E. West nile virus: Immunity and pathogenesis. Viruses 2011, 3, 811-828.
56. Garcia-Tapia, D.; Loiacono, C.M.; Klelboeker, S.B. Replication of west nile virus in equine peripheral blood mononuclear cells. Vet. Immunol. Immunopathol. 2006, 110, 229-244.
57. Hunsperger, E.A.; Roehrig, J.T. Temporal analyses of the neuropathogenesis of a west nile virus infection in mice. J. Neurovirol. 2006, 12, 129-139.
58. Rios, M.; Zhang, M.J.; Grinev, A.; Srinivasan, K.; Daniel, S.; Wood, O.; Hewlett, I.K.; Dayton, A.I. Monocytes-macrophages are a potential target in human infection with west nile virus through blood transfusion. Transfusion (Paris) 2006, 46, 659-667.
59. Wang, S.; Welte, T.; McGargill, M.; Town, T.; Thompson, J.; Anderson, J.F.; Flavell, R.A.; Fikrig, E.; Hedrick, S.M.; Wang, T. Drak2 contributes to west nile virus entry into the brain and lethal encephalitis. J. Immunol. 2008, 181, 2084-2091.
60. King, N.J.; Getts, D.R.; Getts, M.T.; Rana, S.; Shrestha, B.; Kesson, A.M. Immunopathology of flavivirus infections. Immunol. Cell Biol. 2007, 85, 33-42.
61. Bielefeldt-Ohmann, H.; Smirnova, N.P.; Tolnay, A.E.; Webb, B.T.; Antoniazzi, A.Q.; van Campen, H.; Hansen, T.R. Neuro-invasion by a 'trojan horse' strategy and vasculopathy during intrauterine flavivirus infection. Int. J. Exp. Pathol. 2012, 93, 24-33.
62. Li, J.K.; Liang, J.J.; Liao, C.L.; Lin, Y.L. Autophagy is involved in the early step of japanese encephalitis virus infection. Microbes Infect. 2012, 14, 159-168.
63. Hong, R.; Bai, W.Y.; Zhai, J.W.; Liu, W.; Li, X.Y.; Zhang, J.M.; Cui, X.X.; Zhao, X.; Ye, X.L.; Deng, Q.; et al. Novel recombinant hepatitis b virus vectors efficiently deliver protein and rna encoding genes into primary hepatocytes. J. Virol. 2013, 87, 6615-6624.
64. Samuel, M.A.; Wang, H.; Siddharthan, V.; Morrey, J.D.; Diamond, M.S. Axonal transport mediates west nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc. Natl. Acad. Sci. USA 2007, 104, 17140-17145.
65. Wang, H.; Siddharthan, V.; Hall, J.O.; Morrey, J.D. West nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. J. Neurovirol. 2009, 15, 293-299.
66. Lorenz, M.D.; Coates, J.R.; Kent, M. Handbook of Veterinary Neurology, 5th ed.; Elsevier/Saunders: St. Louis, MI, USA, 2011; p. 28.
67. Antoine, J.C.; Honnorat, J.; Camdessanche, J.P.; Magistris, M.; Absi, L.; Mosnier, J.F.; Petiot, P.; Kopp, N.; Michel, D. Paraneoplastic anti-cv2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann. Neurol. 2001, 49, 214-221.
68. Wang, H.; Siddharthan, V.; Hall, J.O.; Morrey, J.D. Autonomic nervous dysfunction in hamsters infected with west nile virus. PLoS One 2011, 6, e19575.
69. Brault, J.B.; Kudelko, M.; Vidalain, P.O.; Tangy, F.; Despres, P.; Pardigon, N. The interaction of flavivirus m protein with light chain tctex-1 of human dynein plays a role in late stages of virus replication. Virology 2011, 417, 369-378.
70. Hunsperger, E.A.; Roehrig, J.T. Nocodazole delays viral entry into the brain following footpad inoculation with west nile virus in mice. J. Neurovirol. 2009, 15, 211-218.
71. Monath, T.P.; Cropp, C.B.; Harrison, A.K. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab. Invest. 1983, 48, 399-410.
72. Nir, Y.; Beemer, A.; Goldwasser, R.A. West nile virus infection in mice following exposure to a viral aerosol. Br. J. Exp. Pathol. 1965, 46, 443.
73. McMinn, P.C.; Dalgarno, L.; Weir, R.C. A comparison of the spread of murray valley encephalitis viruses of high or low neuroinvasiveness in the tissues of swiss mice after peripheral inoculation. Virology 1996, 220, 414-423.
74. Grevers, G.; Herrmann, U. Fenestrated endothelia in vessels of the nasal mucosa. An electron-microscopic study in the rabbit. Arch. Otorhinolaryngol. 1987, 244, 55-60.
75. Yamada, M.; Nakamura, K.; Yoshii, M.; Kaku, Y.; Narita, M. Brain lesions induced by experimental intranasal infection of japanese encephalitis virus in piglets. J. Comp. Pathol. 2009, 141, 156-162.
76. Guarner, J.; Shieh, W.J.; Hunter, S.; Paddock, C.D.; Morken, T.; Campbell, G.L.; Marfin, A.A.; Zaki, S.R. Clinicopathologic study and laboratory diagnosis of 23 cases with west nile virus encephalomyelitis. Hum. Pathol. 2004, 35, 983-990.
77. Morrey, J.D.; Olsen, A.L.; Siddharthan, V.; Motter, N.E.; Wang, H.; Taro, B.S.; Chen, D.; Ruffner, D.; Hall, J.O. Increased blood-brain barrier permeability is not a primary determinant for lethality of west nile virus infection in rodents. J. Gen. Virol. 2008, 89, 467-473.
78. Ichikawa, H.; Itoh, K. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging. Brain Res. 2011, 1390, 142-149.
79. Abbott, N.J.; Rönnbäck, L.; Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7, 41-53.
80. Saunders, N.R.; Habgood, M.D.; Dziegielewska, K.M. Barrier mechanisms in the brain, ii. Immature brain. Clin. Exp. Pharmacol. Physiol. 1999, 26, 85-91.
81. Saunders, N.R.; Liddelow, S.A.; Dziegielewska, K.M. Barrier mechanisms in the developing brain. Front. Pharmacol. 2012, 3, 1-18.
82. Saunders, N.R.; Ek, C.J.; Habgood, M.D.; Dziegielewska, K.M. Barriers in the brain: A renaissance? Trends Neurosci. 2008, 31, 279-286.
83. Segal, M.B. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell. Mol. Neurobiol. 2000, 20, 183-196.
84. Langlet, F.; Mullier, A.; Bouret, S.G.; Prevot, V.; Dehouck, B. Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J. Comp. Neurol. 2013, 521, 3389-3405.
85. Allt, G.; Lawrenson, J.G. Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Brain Res. Rev. 1997, 24, 67-76.
86. Reina, M.A.; De Leon Casasola Ode, L.; Villanueva, M.C.; Lopez, A.; Maches, F.; de Andres, J.A. Ultrastructural findings in human spinal pia mater in relation to subarachnoid anesthesia. Anesth. Analg. 2004, 98, 1479-1485.
87. Clay, C.C.; Rodrigues, D.S.; Ho, Y.S.; Fallert, B.A.; Janatpour, K.; Reinhart, T.A.; Esser, U. Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J. Virol. 2007, 81, 12040-12048.
88. Chaves, A.J.; Busquets, N.; Valle, R.; Rivas, R.; Vergara-Alert, J.; Dolz, R.; Ramis, A.; Darji, A.; Majo, N. Neuropathogenesis of a highly pathogenic avian influenza virus (h7n1) in experimentally infected chickens. Vet. Res. 2011, 42, 106.
89. Frost, M.J.; Zhang, J.; Edmonds, J.H.; Prow, N.A.; Gu, X.; Davis, R.; Hornitzky, C.; Arzey, K.E.; Finlaison, D.; Hick, P.; et al. Characterization of virulent west nile virus kunjin strain, australia, 2011. Emerg. Infect. Dis. 2012, 18, 792-800.
90. Audsley, M.; Edmonds, J.; Liu, W.; Mokhonov, V.; Mokhonova, E.; Melian, E.B.; Prow, N.; Hall, R.A.; Khromykh, A.A. Virulence determinants between new york 99 and kunjin strains of west nile virus. Virology 2011, 414, 63-73.
91. Winkler, E.A.; Sengillo, J.D.; Bell, R.D.; Wang, J.; Zlokovic, B.V. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J. Cereb. Blood Flow Metab. 2012, 32, 1841-1852.
92. Bartanusz, V.; Jezova, D.; Alajajian, B.; Digicaylioglu, M. The blood-spinal cord barrier: Morphology and clinical implications. Ann. Neurol. 2011, 70, 194-206.
93. Prow, N.A.; Irani, D.N. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp. Neurol. 2007, 205, 461-470.
94. Brault, A.C. Changing patterns of west nile virus transmission: Altered vector competence and host susceptibility. Vet. Res. 2009, 40, 1-19.
95. May, F.J.; Davis, C.T.; Tesh, R.B.; Barrett, A.D. Phylogeography of west nile virus: From the cradle of evolution in africa to eurasia, australia, and the americas. J. Virol. 2011, 85, 2964-2974.
96. McMullen, A.R.; Albayrak, H.; May, F.J.; Davis, C.T.; Beasley, D.W.; Barrett, A.D. Molecular evolution of lineage 2 west nile virus. J. Gen. Virol. 2013, 94, 318-325.
97. Beasley, D.W.C.; Whiteman, M.C.; Zhang, S.L.; Huang, C.Y.H.; Schneider, B.S.; Smith, D.R.; Gromowski, G.D.; Higgs, S.; Kinney, R.M.; Barrett, A.D.T. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 west nile virus strains. J. Virol. 2005, 79, 8339-8347.
98. Appler, K.K.; Brown, A.N.; Stewart, B.S.; Behr, M.J.; Demarest, V.L.; Wong, S.J.; Bernard, K.A. Persistence of west nile virus in the central nervous system and periphery of mice. PLoS One 2010, 5, e10649.
99. Morrey, J.D.; Siddharthan, V.; Wang, H.; Hall, J.O. Respiratory insufficiency correlated strongly with mortality of rodents infected with west nile virus. PLoS One 2012, 7, e38672.
100. Langevin, S.A.; Bowen, R.A.; Ramey, W.N.; Sanders, T.A.; Maharaj, P.D.; Fang, Y.; Cornelius, J.; Barker, C.M.; Reisen, W.K.; Beasley, D.W.; et al. Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a mexican west nile virus isolate. J. Gen. Virol. 2011, 92, 2810-2820.
101. Whiteman, M.C.; Li, L.; Wicker, J.A.; Kinney, R.M.; Huang, C.; Beasley, D.W.; Chung, K.M.; Diamond, M.S.; Solomon, T.; Barrett, A.D. Development and characterization of non-glycosylated e and ns1 mutant viruses as a potential candidate vaccine for west nile virus. Vaccine 2010, 28, 1075-1083.
102. Hall, R.A.; Khromykh, A.A.; Mackenzie, J.M.; Scherret, J.H.; Khromykh, T.I.; Mackenzie, J.S. Loss of dimerisation of the nonstructural protein ns1 of kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of ns1. Virology 1999, 264, 66-75.
103. Whiteman, M.C.; Wicker, J.A.; Kinney, R.M.; Huang, C.Y.; Solomon, T.; Barrett, A.D. Multiple amino acid changes at the first glycosylation motif in ns1 protein of west nile virus are necessary for complete attenuation for mouse neuroinvasiveness. Vaccine 2011, 29, 9702-9710.
104. Melian, E.B.; Hinzman, E.; Nagasaki, T.; Firth, A.E.; Wills, N.M.; Nouwens, A.S.; Blitvich, B.J.; Leung, J.; Funk, A.; Atkins, J.F.; et al. Ns1' of flaviviruses in the japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J. Virol. 2010, 84, 1641-1647.
105. Liu, W.J.; Wang, X.J.; Clark, D.C.; Lobigs, M.; Hall, R.A.; Khromykh, A.A. A single amino acid substitution in the west nile virus nonstructural protein ns2a disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 2006, 80, 2396-2404.
106. Brault, A.C.; Huang, C.Y.; Langevin, S.A.; Kinney, R.M.; Bowen, R.A.; Ramey, W.N.; Panella, N.A.; Holmes, E.C.; Powers, A.M.; Miller, B.R. A single positively selected west nile viral mutation confers increased virogenesis in american crows. Nat. Genet. 2007, 39, 1162-1166.
107. Mertens, E.; Kajaste-Rudnitski, A.; Torres, S.; Funk, A.; Frenkiel, M.-P.; Iteman, I.; Khromykh, A.A.; Desprès, P. Viral determinants in the ns3 helicase and 2k peptide that promote west nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. Virology 2010, 399, 176-185.
108. Zou, G.; Puig-Basagoiti, F.; Zhang, B.; Qing, M.; Chen, L.; Pankiewicz, K.W.; Felczak, K.; Yuan, Z.; Shi, P.Y. A single-amino acid substitution in west nile virus 2k peptide between ns4a and ns4b confers resistance to lycorine, a flavivirus inhibitor. Virology 2009, 384, 242-252.
109. Davis, C.T.; Beasley, D.W.; Guzman, H.; Siirin, M.; Parsons, R.E.; Tesh, R.B.; Barrett, A.D. Emergence of attenuated west nile virus variants in texas, 2003. Virology 2004, 330, 342-350.
110. Wicker, J.A.; Whiteman, M.C.; Beasley, D.W.; Davis, C.T.; McGee, C.E.; Lee, J.C.; Higgs, S.; Kinney, R.M.; Huang, C.Y.; Barrett, A.D. Mutational analysis of the west nile virus ns4b protein. Virology 2012, 426, 22-33.
111. Welte, T.; Xie, G.; Wicker, J.A.; Whiteman, M.C.; Li, L.; Rachamallu, A.; Barrett, A.; Wang, T. Immune responses to an attenuated west nile virus ns4b-p38g mutant strain. Vaccine 2011, 29, 4853-4861.
112. Wicker, J.A.; Whiteman, M.C.; Beasley, D.W.; Davis, C.T.; Zhang, S.; Schneider, B.S.; Higgs, S.; Kinney, R.M.; Barrett, A.D. A single amino acid substitution in the central portion of the west nile virus ns4b protein confers a highly attenuated phenotype in mice. Virology 2006, 349, 245-253.
113. Puig-Basagoiti, F.; Tilgner, M.; Bennett, C.J.; Zhou, Y.; Munoz-Jordan, J.L.; Garcia-Sastre, A.; Bernard, K.A.; Shi, P.Y. A mouse cell-adapted ns4b mutation attenuates west nile virus rna synthesis. Virology 2007, 361, 229-241.
114. Hunt, T.A.; Urbanowski, M.D.; Kakani, K.; Law, L.M.; Brinton, M.A.; Hobman, T.C. Interactions between the west nile virus capsid protein and the host cell-encoded phosphatase inhibitor, i2pp2a. Cell. Microbiol. 2007, 9, 2756-2766.
115. van Marle, G.; Antony, J.; Ostermann, H.; Dunham, C.; Hunt, T.; Halliday, W.; Maingat, F.; Urbanowski, M.D.; Hobman, T.; Peeling, J.; et al. West nile virus-induced neuroinflammation: Glial infection and capsid protein-mediated neurovirulence. J. Virol. 2007, 81, 10933-10949.
116. Chu, J.J.H.; Rajamanonmani, R.; Li, J.; Bhuvanakantham, R.; Lescar, J.; Ng, M.L. Inhibition of west nile virus entry by using a recombinant domain iii from the envelope glycoprotein. J. Gen. Virol. 2005, 86, 405-412.
117. Evans, J.D.; Seeger, C. Differential effects of mutations in ns4b on west nile virus replication and inhibition of interferon signaling. J. Virol. 2007, 81, 11809-11816.
118. Laurent-Rolle, M.; Boer, E.F.; Lubick, K.J.; Wolfinbarger, J.B.; Carmody, A.B.; Rockx, B.; Liu, W.; Ashour, J.; Shupert, W.L.; Holbrook, M.R.; et al. The ns5 protein of the virulent west nile virus ny99 strain is a potent antagonist of type i interferon-mediated jak-stat signaling. J. Virol. 2010, 84, 3503-3515.
119. Xiao, S.Y.; Guzman, H.; Zhang, H.; Travassos da Rosa, A.P.; Tesh, R.B. West nile virus infection in the golden hamster (mesocricetus auratus): A model for west nile encephalitis. Emerg. Infect. Dis. 2001, 7, 714-721.
120. Bunning, M.L.; Bowen, R.A.; Cropp, C.B.; Sullivan, K.G.; Davis, B.S.; Komar, N.; Godsey, M.S.; Baker, D.; Hettler, D.L.; Holmes, D.A.; et al. Experimental infection of horses with west nile virus. Emerg. Infect. Dis. 2002, 8, 380-386.
121. Sejvar, J.J.; Marfin, A.A. Manifestations of west nile neuroinvasive disease. Rev. Med. Virol. 2006, 16, 209-224.
122. Lanciotti, R.S.; Kerst, A.J.; Nasci, R.S.; Godsey, M.S.; Mitchell, C.J.; Savage, H.M.; Komar, N.; Panella, N.A.; Allen, B.C.; Volpe, K.E.; et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a taqman reverse transcriptase-pcr assay. J. Clin. Microbiol. 2000, 38, 4066-4071.
123. Shrestha, B.; Zhang, B.; Purtha, W.E.; Klein, R.S.; Diamond, M.S. Tumor necrosis factor alpha protects against lethal west nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J. Virol. 2008, 82, 8956-8964.
124. Tesh, R.B.; Siirin, M.; Guzman, H.; da Rosa, A.; Wu, X.Y.; Duan, T.; Lei, H.; Nunes, M.R.; Xiao, S.Y. Persistent west nile virus infection in the golden hamster: Studies on its mechanism and possible implications for other flavivirus infections. J. Infect. Dis. 2005, 192, 287-295.
125. Tonry, J.H.; Xiao, S.Y.; Siirin, M.; Chen, H.; da Rosa, A.P.; Tesh, R.B. Persistent shedding of west nile virus in urine of experimentally infected hamsters. Am. J. Trop. Med. Hyg. 2005, 72, 320-324.
126. Ding, X.; Wu, X.; Duan, T.; Siirin, M.; Guzman, H.; Yang, Z.; Tesh, R.B.; Xiao, S.Y. Nucleotide and amino acid changes in west nile virus strains exhibiting renal tropism in hamsters. Am. J. Trop. Med. Hyg. 2005, 73, 803-807.
127. Cantile, C.; di Guardo, G.; Eleni, C.; Arispici, M. Clinical and neuropathological features of west nile virus equine encephalomyelitis in italy. Equine Vet. J. 2000, 32, 31-35.
128. Smith, R.D.; Konoplev, S.; DeCourten-Myers, G.; Brown, T. West nile virus encephalitis with myositis and orchitis. Hum. Pathol. 2004, 35, 254-258.
129. Tonry, J.H.; Brown, C.B.; Cropp, C.B.; Co, J.K.G.; Bennett, S.N.; Nerurkar, V.R.; Kuberski, T.; Gubler, D.J. West nile virus detection in urine. Emerg. Infect. Dis. 2005, 11, 1294-1296.
130. Omalu, B.I.; Shakir, A.A.; Wang, G.; Lipkin, W.I.; Wiley, C.A. Fatal fulminant pan-meningo-polioencephalitis due to west nile virus. Brain Pathol. 2003, 13, 465-472.
131. Agamanolis, D.P.; Leslie, M.J.; Caveny, E.A.; Guarner, J.; Shieh, W.J.; Zaki, S.R. Neuropathological findings in west nile virus encephalitis: A case report. Ann. Neurol. 2003, 54, 547-551.
132. Bielefeldt-Ohmann, H.; Bosco-Lauth, A.; Tolnay, A.E.; Prow, N.A.; Wang, W.; Khromykh, A.A.; Hall, R.A.; Bowen, R. Experimental infection of horses with the equine-pathogenic west nile virus strain wnvnsw 2011-Comparison to natural cases. University of Queensland, St. Lucia, Qld, Australia. Unpublished work, 2013.
133. O'Leary, D.R.; Marfin, A.A.; Montgomery, S.P.; Kipp, A.M.; Lehman, J.A.; Biggerstaff, B.J.; Elko, V.L.; Collins, P.D.; Jones, J.E.; Campbell, G.L. The epidemic of west nile virus in the united states, 2002. Vector Borne Zoonotic Dis. 2004, 4, 61-70.
134. Mostashari, F.; Bunning, M.L.; Kitsutani, P.T.; Singer, D.A.; Nash, D.; Cooper, M.J.; Katz, N.; Liljebjelke, K.A.; Biggerstaff, B.J.; Fine, A.D.; et al. Epidemic west nile encephalitis, new york, 1999: Results of a household-based seroepidemiological survey. Lancet 2001, 358, 261-264.
135. Kleinschmidt-DeMasters, B.K.; Marder, B.A.; Levi, M.E.; Laird, S.P.; McNutt, J.T.; Escott, E.J.; Everson, G.T.; Tyler, K.L. Naturally acquired west nile virus encephalomyelitis in transplant recipients-clinical, laboratory, diagnostic, and neuropathological features. Arch. Neurol. 2004, 61, 1210-1220.
136. Diamond, M.S.; Mehlhop, E.; Oliphant, T.; Samuel, M.A. The host immunologic response to west nile encephalitis virus. Front. Biosci. (Landmark Ed) 2009, 14, 3024-3034.
137. Seok, J.; Warren, H.S.; Cuenca, A.G.; Mindrinos, M.N.; Baker, H.V.; Xu, W.; Richards, D.R.; McDonald-Smith, G.P.; Gao, H.; Hennessy, L.; et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2013, 110, 3507-3512.
138. Ratterree, M.S.; Gutierrez, R.A.; Travassos da Rosa, A.P.; Dille, B.J.; Beasley, D.W.; Bohm, R.P.; Desai, S.M.; Didier, P.J.; Bikenmeyer, L.G.; Dawson, G.J.; et al. Experimental infection of rhesus macaques with west nile virus: Level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 2004, 189, 669-676.
139. Verstrepen, B.E.; Fagrouch, Z.; van Heteren, M.; Buitendijk, H.; Haaksma, T.; Beenhakker, N.; Palu, G.; Richner, J.M.; Diamond, M.S.; Bogers, W.M.; et al. Experimental infection of rhesus macaques and common marmosets with a european strain of west nile virus. PLoS Negl. Trop. Dis. 2014, 8, e2797.
140. Suen, W.; Prow, N.A.; Wang, W.; Broad, N.; Hall, R.A.; Kirkland, P.; Bielefeldt-Ohmann, H. The establishment of a rabbit model to elucidate the mechanism of neuroinvasion by an emergent australian west nile virus. In Proceedings of The 7th Australasian Virology Society Meeting, Queenstown, New Zealand, 8-11 December 2013; p. 97.
141. Lee, H.H.; Hong, S.K.; Yoon, S.H.; Jang, S.J.; Bahk, Y.Y.; Song, M.D.; Park, P.J.; Lee, K.H.; Kim, C.G.; Kim, B.; et al. Immunogenicity of japanese encephalitis virus envelope protein by hyphantria cunea nuclear polyhedrosis virus vector in guinea pig. Appl. Biochem. Biotechnol. 2012, 167, 259-269.
142. Fenton, R.J.; Clark, A.; Potter, C.W. Immunity to influenza in ferrets. Xiv: Comparative immunity following infection or immunization with live or inactivated vaccine. Br. J. Exp. Pathol. 1981, 62, 297-307.
143. Clarke, P.; Leser, J.S.; Quick, E.D.; Dionne, K.R.; Beckham, J.D.; Tyler, K.L. Death receptor-mediated apoptotic signaling is activated in the brain following infection with west nile virus in the absence of a peripheral immune response. J. Virol. 2014, 88, 1080-1089.